690 related articles for article (PubMed ID: 29521057)
1. Urine nerve growth factor (NGF) level, bladder nerve staining and symptom/problem scores in patients with interstitial cystitis.
Tonyali S; Ates D; Akbiyik F; Kankaya D; Baydar D; Ergen A
Adv Clin Exp Med; 2018 Feb; 27(2):159-163. PubMed ID: 29521057
[TBL] [Abstract][Full Text] [Related]
2. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.
Liu HT; Tyagi P; Chancellor MB; Kuo HC
BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864
[TBL] [Abstract][Full Text] [Related]
3. Urinary nerve growth factor correlates with the severity of urgency and pain.
Kim SW; Im YJ; Choi HC; Kang HJ; Kim JY; Kim JH
Int Urogynecol J; 2014 Nov; 25(11):1561-7. PubMed ID: 24866276
[TBL] [Abstract][Full Text] [Related]
4. Increased urine and serum nerve growth factor levels in interstitial cystitis suggest chronic inflammation is involved in the pathogenesis of disease.
Liu HT; Kuo HC
PLoS One; 2012; 7(9):e44687. PubMed ID: 23028581
[TBL] [Abstract][Full Text] [Related]
5. Urinary nerve growth factor could be a biomarker for interstitial cystitis/painful bladder syndrome: a meta-analysis.
Qu HC; Zhang W; Yan S; Liu YL; Wang P
PLoS One; 2014; 9(9):e106321. PubMed ID: 25181532
[TBL] [Abstract][Full Text] [Related]
6. Symptomatic overlap in overactive bladder and interstitial cystitis/bladder pain syndrome: development of a new algorithm.
Ackerman AL; Lai HH; Parameshwar PS; Eilber KS; Anger JT
BJU Int; 2019 Apr; 123(4):682-693. PubMed ID: 30253040
[TBL] [Abstract][Full Text] [Related]
7. Decrease of urinary nerve growth factor but not brain-derived neurotrophic factor in patients with interstitial cystitis/bladder pain syndrome treated with hyaluronic acid.
Jiang YH; Liu HT; Kuo HC
PLoS One; 2014; 9(3):e91609. PubMed ID: 24614892
[TBL] [Abstract][Full Text] [Related]
8. Urinary ATP may be a biomarker of interstitial cystitis/bladder pain syndrome and its severity.
Wu Y; He Y; Qi J; Wang S; Wang Z
Biomol Biomed; 2024 Jan; 24(1):170-175. PubMed ID: 37819233
[TBL] [Abstract][Full Text] [Related]
9. Elevated Urine Levels of Macrophage Migration Inhibitory Factor in Inflammatory Bladder Conditions: A Potential Biomarker for a Subgroup of Interstitial Cystitis/Bladder Pain Syndrome Patients.
Vera PL; Preston DM; Moldwin RM; Erickson DR; Mowlazadeh B; Ma F; Kouzoukas DE; Meyer-Siegler KL; Fall M
Urology; 2018 Jun; 116():55-62. PubMed ID: 29580781
[TBL] [Abstract][Full Text] [Related]
10. Increased severity of inflammation correlates with elevated expression of TRPV1 nerve fibers and nerve growth factor on interstitial cystitis/bladder pain syndrome.
Liu BL; Yang F; Zhan HL; Feng ZY; Zhang ZG; Li WB; Zhou XF
Urol Int; 2014; 92(2):202-8. PubMed ID: 24458144
[TBL] [Abstract][Full Text] [Related]
11. [Experimental evaluation of interaction of the nerve growth factor and mast cells in patients with interstitial cystitis/bladder pain syndrome].
Sholan RF
Urologiia; 2020 Apr; (2):31-34. PubMed ID: 32351060
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis in bladder tissues is strongly correlated with urinary frequency and bladder pain in patients with interstitial cystitis/bladder pain syndrome.
Furuta A; Suzuki Y; Igarashi T; Koike Y; Kimura T; Egawa S; Yoshimura N
Int J Urol; 2019 Jun; 26 Suppl 1():35-40. PubMed ID: 31144750
[TBL] [Abstract][Full Text] [Related]
13. Could urinary nerve growth factor be a biomarker for overactive bladder? A meta-analysis.
Sheng W; Zhang H; Ruth KH
Neurourol Urodyn; 2017 Sep; 36(7):1703-1710. PubMed ID: 28102552
[TBL] [Abstract][Full Text] [Related]
14. Clinical characterization of interstitial cystitis/bladder pain syndrome in women based on the presence or absence of Hunner lesions and glomerulations.
Watanabe D; Akiyama Y; Niimi A; Nomiya A; Yamada Y; Sato Y; Nakamura M; Kawai T; Yamada D; Suzuki M; Igawa Y; Kume H; Homma Y
Low Urin Tract Symptoms; 2021 Jan; 13(1):139-143. PubMed ID: 32830459
[TBL] [Abstract][Full Text] [Related]
15. Sensory Hyperinnervation Distinguishes Bladder Pain Syndrome/Interstitial Cystitis from Overactive Bladder Syndrome.
Regauer S; Gamper M; Fehr MK; Viereck V
J Urol; 2017 Jan; 197(1):159-166. PubMed ID: 27378135
[TBL] [Abstract][Full Text] [Related]
16. Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C.
Gamper M; Viereck V; Eberhard J; Binder J; Moll C; Welter J; Moser R
Int Urogynecol J; 2013 Dec; 24(12):2049-57. PubMed ID: 23670165
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome and symptom improvement in patients with interstitial cystitis/bladder pain syndrome with or without regular follow-up and treatment.
Yeh HL; Jhang JF; Kuo YC; Kuo HC
Neurourol Urodyn; 2019 Sep; 38(7):1985-1993. PubMed ID: 31310370
[TBL] [Abstract][Full Text] [Related]
18. Reliability and validity of Turkish versions of the interstitial cystitis symptom index and interstitial cystitis problem index.
Esen B; Obaid K; Süer E; Gökçe Mİ; Gökmen D; Bedük Y; Gülpınar Ö
Neurourol Urodyn; 2020 Nov; 39(8):2338-2343. PubMed ID: 32846036
[TBL] [Abstract][Full Text] [Related]
19. Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)?
Seth JH; Sahai A; Khan MS; van der Aa F; de Ridder D; Panicker JN; Dasgupta P; Fowler CJ
BJU Int; 2013 Mar; 111(3):372-80. PubMed ID: 23444927
[TBL] [Abstract][Full Text] [Related]
20. Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis/bladder pain syndrome and detrusor overactivity.
Liu HT; Tyagi P; Chancellor MB; Kuo HC
BJU Int; 2010 Dec; 106(11):1681-5. PubMed ID: 19751258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
